EUVIMEDEUVIMED entdecken
Crossref

Systemic administration of poly(I:C) and resiquimod reprograms tumor-associated macrophages and prevents tumor progression and metastasis in murine cancer models

Clément Anfray, Alba Pensado-López, Flávia Castro, Ailenis Rosales Sánchez, Iván Sandino Somoza, Aldo Ummarino, Jon Ander Simon, Sergio Leon, Alfonso Calvo, María José Oliveira, Jérôme Toutain, Samuel Valable und 3 weitere

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Clément Anfray und 14 weiteren Autor:innen. Beteiligte Einrichtung: Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Humanitas Research Hospital, Rozzano, Milan, 20089, Italy; Université de Caen Normandie,…. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Poly I-C, Imidazoles, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, European Regional Development Fund, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-associated macrophages (TAMs) drive the immunosuppressive tumor microenvironment (TME), promoting oncogenic progression, metastasis and treatment resistance. While we previously established that intratumoral administration of poly(I:C) and R848 (TLR3 and TLR7/8 agonists) has strong therapeutic efficacy and triggers STAT1-mediated TAM reprogramming superior to monotherapies, this study evaluates the translational potential, systemic tolerability and immunological impact of their combined systemic (intravenous) delivery. Across diverse syngeneic murine models of solid tumors, including lung adenocarcinoma, triple-negative breast cancer (TNBC), fibrosarcoma and glioblastoma, systemic poly(I:C) + R848 administration significantly inhibited primary tumor growth and spontaneous lung metastasis. The treatment exhibited good tolerability under the conditions tested, with no body weight loss or histopathological damage to major organs. Treatment triggered a transient trend toward elevation of pro-inflammatory cytokines (TNF-α, IFN-γ, CXCL10, CCL5), while anti-inflammatory markers (IL-10, IL-4) remained unchanged. In primary tumors, treatment-induced TAM reprogramming was evidenced by upregulated M1-like markers (Irf7, Ccl5) and decreased M2-like markers (Arg1), accompanied by enhanced Cd8 and Cd4 T cell markers and cytotoxic effectors (Prf-1 and Gzmb). Multispectral immunophenotyping confirmed this shift toward an antitumor macrophage phenotype, characterized by increased CD86 and decreased ARG1 across all primary tumors. Furthermore, treatment significantly prevented lung metastasis and tumor-induced splenomegaly, shifting splenic macrophages toward an elevated M1/M2 ratio in both fibrosarcoma and TNBC models. These findings demonstrate that intravenous administration of the poly(I:C) + R848 combination effectively reprograms TAMs, suppressing tumor progression and preventing metastasis across a variety of preclinical models of difficult-to-treat solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor-Associated MacrophagesPoly I-CImidazolesAntineoplastic Combined Chemotherapy ProtocolsAnimalsFemaleToll-Like Receptor AgonistsTumor MicroenvironmentDisease ProgressionMiceCell Line, TumorHumansNeoplasm MetastasisMice, Inbred C57BLCytokinesLung Neoplasms

Stichwörter der Autor:innen

Combination therapyImmunotherapyMacrophageToll-like receptor

Substanzen

resiquimodPoly I-CImidazolesToll-Like Receptor AgonistsCytokines

Autor:innen und Institutionen

  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Humanitas Research Hospital, Rozzano, Milan, 20089, Italy; Université de Caen Normandie, CNRS, Normandie Université, ISTCT UMR6030, GIP CYCERON, Caen, F-14000…
  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Humanitas Research Hospital, Rozzano, Milan, 20089, Italy; Medical Oncology Department, Fundación Pública Galega de Investigación Biomédica (INIBIC), Complexo…
  • i3S-Instituto de Investigação e Inovação em Saúde da Universidade de Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal. Electronic address: flaviateixeiracastro@i3s.up.pt.
  • Medical Oncology Department, Fundación Pública Galega de Investigación Biomédica (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, 15006, Spain. Electronic address: ailenis.rosales.sanchez@ser…
  • Medical Oncology Department, Fundación Pública Galega de Investigación Biomédica (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, 15006, Spain. Electronic address: ivan.sandino.somoza@sergas.…
  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Humanitas Research Hospital, Rozzano, Milan, 20089, Italy; Department of Biomedical Sciences, Humanitas University, Milan, 20072, Italy. Electronic address: a…

Förderung

  • Instituto de Salud Carlos III
  • European Regional Development Fund
  • Fundação para a Ciência e a Tecnologia
  • Ministerio de Ciencia, Innovación y Universidades
  • Peoria County Bar Association
  • European Commission
  • Xunta de Galicia
  • Worldwide Cancer Research

Zitieren

APA

Anfray, C., Pensado-López, A., Castro, F., Rosales Sánchez, A., Sandino Somoza, I., Ummarino, A., Simon, J. A., Leon, S., Calvo, A., Oliveira, M. J., Toutain, J., Valable, S., García Campelo, R., Allavena, P., & Torres Andón, F. (2026). Systemic administration of poly(I:C) and resiquimod reprograms tumor-associated macrophages and prevents tumor progression and metastasis in murine cancer models. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218893

Vancouver

Anfray C, Pensado-López A, Castro F, Rosales Sánchez A, Sandino Somoza I, Ummarino A, et al. Systemic administration of poly(I:C) and resiquimod reprograms tumor-associated macrophages and prevents tumor progression and metastasis in murine cancer models. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218893

BibTeX
@article{Anfray2026,
  author = {Anfray, Clément and Pensado-López, Alba and Castro, Flávia and Rosales Sánchez, Ailenis and Sandino Somoza, Iván and Ummarino, Aldo and Simon, Jon Ander and Leon, Sergio and Calvo, Alfonso and Oliveira, María José and Toutain, Jérôme and Valable, Samuel and García Campelo, Rosario and Allavena, Paola and Torres Andón, Fernando},
  title = {Systemic administration of poly(I:C) and resiquimod reprograms tumor-associated macrophages and prevents tumor progression and metastasis in murine cancer models},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218893}
}
Kostenlos starten →